Page 40 - BH-2-1
P. 40

Brain & Heart                                                                 Practical tips for AD and PD



               word remembered. In the delayed recall stage, conducted   •   CDR-4: Profound dementia
               after three additional tests, patients were asked to recall   •   CDR-5: Terminal dementia.
               the words they previously learned. In the next step, a   The overall CDR score was used to group patients
               mixed list of 20 words, including 10 new words of similar   according to the severity of dementia .
                                                                                            [26]
               nature, such as mosque, five, mountain, string, coffee, lira,   (10) Blessed Dementia Rating Scale (BDRS). BDRS consists
               slippers, soldier, hotel, and village, was presented to the   of 22 items and quantifies the degree of intellectual
               patient, who was then asked to recognize the previously   and personality deterioration in the elderly. BDRS
               learned words. The total score for correct positive and   reflects changes in daily performance, habits including
               false negative conditions in this stage is 20. During the   self-care, and personality. The BDRS is scored on a
               administration of this test, a second pause was given   0–28 point scale, where higher points indicate a larger
               before proceeding to the next task, and feedback about   decrement in functional capacity .
                                                                                             [27]
               patient responses was not provided .              For evaluating PD patients’ daily living activities and
                                          [22]
            (6)  Boston Naming Test (BNT).  It  is  a  widely  used   disease staging, MDS-Unified Parkinson’s Disease Rating
               neuropsychological test that assesses an individual’s   Scale (MDS-UPDRS) was used and all PD patients were
               ability to name objects. The BNT consists of 60-line   evaluated during the period when Parkinson’s patients are
               drawings  of  objects  of  increasing  difficulty,  and  the   active in terms of motor movement (“ON period”) .
                                                                                                       [28]
               participant was asked to name each object. One point
               was awarded for each correctly named object .   2.2. Statistical analysis
                                                   [23]
            (7)  Clock Drawing Test (CDT). It is a widely used   STATISTICA 13.0 statistical program was used for
               neuropsychological test that assesses an individual’s   statistical data entry and analysis. Number and percentage
               ability to draw a clock face and set the hands to a   values were given as descriptive statistics for categorical
               specified time. The CDT is scored on a 10-point   variables and the Chi-square test was used in the analysis
               scale based on the accuracy of the drawing and the   of categorical data. Mean, standard deviation, minimum,
               placement of the hands .                        and maximum values were given as descriptive statistics
                                  [24]
            (8)  The Global  Deterioration Scale (GDS). GDS for AD   for continuous variables satisfying the normal distribution
               is a widely used tool for staging the progression of   condition. One-way analysis of variance (ANOVA)
               cognitive decline in individuals with AD. The GDS is   was used for the variables conforming to the normal
               based on a 7-point scale that ranges from no cognitive   distribution. Tukey’s test was used to determine the
               impairment to severe cognitive decline as follows:  significant difference between pairs of groups. Median,
               -   Grade 1: No cognitive impairment            first quartile (Q1), and third quartile (Q3) values were used
               -   Grade 2: Questionable cognitive impairment  as descriptive statistics for continuous variables that did
               -   Grade 3: Mild cognitive impairment          not meet the normal distribution condition and for these
               -   Grade 4: Moderate cognitive impairment      variables, Kruskall–Wallis test was used for data analysis.
               -   Grade 5: Moderately severe cognitive impairment  Results are given together with 95% confidence interval,
               -   Grade 6: Severe cognitive impairment        and differences with P < 0.05 are considered significant.
               -   Grade 7: Very severe cognitive impairment
              The GDS is a widely used tool in clinical practice and   3. Results
            research to measure the progression of AD. It provides a
            standardized way to assess the severity of cognitive decline   A total of 240 participants, including 115 men (47.9%), and
                                                               125 women (52.1%), with a mean age of 68.9 years, were
            and track changes over time .
                                  [25]
                                                               analyzed in this study. There were differences between the
            (9)  Clinical Dementia Rating Scale (CDR). CDR is a global   AD and PD-D groups in terms of gender distribution, with
               summary measure designed to identify the overall   the female proportion higher in the AD group while the
               severity of dementia. Six different areas are assessed   male proportion was in the PD-D group (P < 0.05). There
               in  this  test, namely,  memory, orientation,  judgment   was also a difference in disease duration between the AD
               and problem-solving, community affairs, home and   and PD-D patient groups, and the disease duration was
               hobbies,  and  personal  care.  The  CDR  is  based  on  a   longer in the PD-D group (P < 0.05). There were differences
               5-point scale as follows:                       in age distribution between the patient groups and the
               •   CDR-0: No cognitive impairment              control group (P < 0.001), but there was no difference in
               •   CDR-0.5: Questionable or very mild dementia  age distribution between the patient groups (P > 0.05). The
               •   CDR-1: Present, but mild dementia           demographic characteristics of patients are summarized in
               •   CDR-2: Moderate dementia                    Table 1. Compared with the control group, the education
               •   CDR-3: Severe dementia                      period was shorter in AD and PD-D groups (P = 0.001).


            Volume 2 Issue 1 (2024)                         4                         https://doi.org/10.36922/bh.1712
   35   36   37   38   39   40   41   42   43   44   45